Sustained remissions with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children with relapsed/refractory ALL

被引：116

作者：

Maude, Shannon L.

Teachey, David T.

Rheingold, Susan R.

Shaw, Pamela A.

Aplenc, Richard

Barrett, David Maxwell

Barker, Christine S.

Callahan, Colleen

Frey, Noelle V.

Nazimuddin, Farzana

Lacey, Simon F.

Zheng, Zhaohui

Levine, Bruce

Melenhorst, Jan Joseph

Motley, Laura

Porter, David L.

June, Carl H.

Grupp, Stephan A.

机构：

[1] Childrens Hosp Philadelphia, Philadelphia, PA USA

[2] Univ Pennsylvania, Philadelphia, PA USA

[3] Univ Pennsylvania, Abramson Canc Ctr, Philadelphia, PA USA

[4] Univ Pennsylvania, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA USA

[5] Univ Pennsylvania, Lymphoma Program, Abramson Canc Ctr, Philadelphia, PA USA

来源：

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.3011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3011

引用

页数：2